Author: OurCrowd

[Databricks in PR Newswire] S&P Global expands collaboration with Databricks with the addition of S&P Capital IQ Pro datasets via Delta Sharing

May 28, 2025 |

NEW YORK, May 28, 2025 /PRNewswire/ — S&P Global (NYSE: SPGI) announced today the addition of several S&P Capital IQ Pro datasets available in Databricks. Powered by Databricks Delta Sharing, this enhanced collaboration between S&P Global and Databricks, the data and AI company, allows users to directly access and query a wide array of additional S&P Global datasets, including financials, estimates, filings, transcripts, transactions, sustainability across investment management, risk, and competitive intelligence use cases — all without the need for data ingestion. Read...

Read More

[CoreMap in GlobeNewswire] CoreMap, Inc. Receives U.S. FDA Investigational Device Exemption (IDE) Approval for INvENI Map-Guided AF Ablation Study

May 28, 2025 |

BURLINGTON, Mass., May 28, 2025 (GLOBE NEWSWIRE) — CoreMap today announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to extend the INvENI clinical study into the U.S. This study is designed to evaluate the safety and effectiveness of the proprietary CoreMap™ Endocardial Electrophysiology (EP) Mapping System in patients with persistent Atrial Fibrillation (AF) and long-standing persistent AF. To date, CoreMap has demonstrated safety and acute effectiveness of its EP Mapping system in over 50 patients. Read...

Read More